SCHEMBL14528673

SCHEMBL14528673

C=C1CC[C@H](O)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLL Q9UGP5 1/20 0.36
NR3C2 P08235 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
AR P10275 1/20 0.33
HSD11B1 P28845 1/20 0.33
AKR1C3 P42330 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
PARP1 P09874 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
CDK8 P49336 1/20 0.31
CDK5 Q00535 1/20 0.31
S1PR1 P21453 3/20 0.31
S1PR2 O95136 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR3 Q99500 1/20 0.31
S1PR5 Q9H228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL136161 0.81 EDNRB (0.34) ADORA3ARHSD11B1AKR1C3CYP1A2
(-)-4-Hydroxy-Alpha-Tetralone SCHEMBL19420220 0.76 POLL (0.50) POLLADORA3ARHSD11B1AKR1C3
SCHEMBL7535293 0.76 HTR2A (0.46) NR3C2ANPEPHTR2A
(-)-4-Hydroxy-Alpha-Tetralone SCHEMBL14592023 0.76 POLL (0.50) POLLADORA3ARHSD11B1AKR1C3
(-)-4-Hydroxy-Alpha-Tetralone SCHEMBL3694170 0.76 POLL (0.50) POLLADORA3ARHSD11B1AKR1C3
SCHEMBL18761553 0.76 ANPEP (0.35) ANPEPHTR2ASLC6A4SLC6A3
SCHEMBL7906603 0.73 POLL (0.34) POLLNR3C2CYP1A2CYP2D6BCHE
SCHEMBL23948898 0.71 S1PR1 (0.42) POLLNR3C2S1PR1S1PR2S1PR4
SCHEMBL20540210 0.71 S1PR1 (0.42) POLLNR3C2S1PR1S1PR2S1PR4
SCHEMBL5206019 0.70 MEN1 (0.41) POLLCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007050795-A2 TRANSGLUTAMINASE INHIBITORS AND METHODS OF USE THEREOF ALVINE PHARMACEUTICALS, INC. (US) 2007-05-03 WO disclosed